Cargando…
miR‐203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver
Liver resection is still the most commonly used therapeutic treatment for hepatocellular carcinoma (HCC), and liver regeneration promotes HCC growth in the regenerating liver. The high recurrence/metastasis of HCC is the main cause of death for HCC patients after liver resection. However, how the au...
Autores principales: | Zheng, Xiao‐Bo, Chen, Xiao‐Bo, Xu, Liang‐Liang, Zhang, Ming, Feng, Lei, Yi, Peng‐Sheng, Tang, Jian‐Wei, Xu, Ming‐Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378262/ https://www.ncbi.nlm.nih.gov/pubmed/28100026 http://dx.doi.org/10.1111/cas.13167 |
Ejemplares similares
-
miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1
por: Zhang, Yi, et al.
Publicado: (2016) -
Downregulation of MiR-203a Disinhibits Bmi1 and Promotes Growth and Proliferation of Keratinocytes in Cholesteatoma
por: Zang, Jian, et al.
Publicado: (2018) -
Inhibition of BCR/ABL Protein Expression by miR-203 Sensitizes for Imatinib Mesylate
por: Li, Yajuan, et al.
Publicado: (2013) -
miR-203 Inhibits Alcohol-Induced Hepatic Steatosis by Targeting Lipin1
por: Cheng, Xiao-Yu, et al.
Publicado: (2018) -
MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG
por: An, Ning, et al.
Publicado: (2020)